Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Interest & Investment Income (2021 - 2025)

Historic Interest & Investment Income for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q3 2025 value amounting to $472000.0.

  • Barinthus Biotherapeutics' Interest & Investment Income fell 2519.81% to $472000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 1623.28%. This contributed to the annual value of $2.7 million for FY2024, which is 691.69% down from last year.
  • Latest data reveals that Barinthus Biotherapeutics reported Interest & Investment Income of $472000.0 as of Q3 2025, which was down 2519.81% from $523000.0 recorded in Q2 2025.
  • In the past 5 years, Barinthus Biotherapeutics' Interest & Investment Income registered a high of $1.6 million during Q1 2023, and its lowest value of $2000.0 during Q1 2021.
  • Over the past 5 years, Barinthus Biotherapeutics' median Interest & Investment Income value was $601000.0 (recorded in 2023), while the average stood at $638187.5.
  • As far as peak fluctuations go, Barinthus Biotherapeutics' Interest & Investment Income skyrocketed by 405000.0% in 2022, and later tumbled by 8085.94% in 2023.
  • Quarter analysis of 5 years shows Barinthus Biotherapeutics' Interest & Investment Income stood at $2000.0 in 2021, then surged by 66250.0% to $1.3 million in 2022, then plummeted by 56.97% to $571000.0 in 2023, then increased by 11.56% to $637000.0 in 2024, then decreased by 25.9% to $472000.0 in 2025.
  • Its Interest & Investment Income was $472000.0 in Q3 2025, compared to $523000.0 in Q2 2025 and $556000.0 in Q1 2025.